Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linlin Sun

Showing results (311-320 of 318) with videos related to

Pageof 32
Sort By:
You have reached the last page of results.This site can display upto 318 results.
Journal of Cancer Research and Clinical Oncology|June 30, 2022
A randomized, open-label, two-cycle, two-crossover phase I clinical trial comparing the bioequivalence and safety of afatinib and Giotrif<sup>®</sup> in healthy Chinese subjectsGuangwen Liu, Jinling Xue, Yanli Wang, et al.
International Journal of Biological Sciences|October 2, 2023
Inhibition of Galectin-9 sensitizes tumors to anthracycline treatment via inducing antitumor immunityXian Sun, Wei-Jan Wang, Jilu Lang, et al.
Frontiers in Pharmacology|September 2, 2022
Effectiveness and safety analysis of SanHanHuaShi granules for the treatment of coronavirus disease 2019: Study protocol and statistical analysis plan for a randomized, parallel-controlled, open-label clinical trialYangyang Liu, Xi Chen, Hongan Wang, et al.
Journal for Immunotherapy of Cancer|July 15, 2025
Anti-galectin-9 therapy synergizes with EGFR inhibition to reprogram the tumor microenvironment and overcome immune evasionDongli Linghu, Jiaming Song, Liyan Gu, et al.
Nature Communications|February 6, 2021
Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapyRiyao Yang, Linlin Sun, Ching-Fei Li, et al.
Neuron|September 13, 2025
Corticotropin-releasing hormone signaling from piriform cortex to amygdala mediates social homophily in opioid addictionYu Huo, Xingyuan Wang, Xiaorui Lin, et al.
Cancer Research|March 12, 2020
Targeting Glycosylated PD-1 Induces Potent Antitumor ImmunityLinlin Sun, Chia-Wei Li, Ezra M Chung, et al.
The Journal of Clinical Investigation|July 16, 2019
IL-6/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasionLi-Chuan Chan, Chia-Wei Li, Weiya Xia, et al.
Pageof 32

Showing results (311-320 of 318) with videos related to

Sort By:
Pageof 32
You have reached the last page of results.This site can display upto 318 results.
Journal of Cancer Research and Clinical Oncology|June 30, 2022
A randomized, open-label, two-cycle, two-crossover phase I clinical trial comparing the bioequivalence and safety of afatinib and Giotrif<sup>®</sup> in healthy Chinese subjectsGuangwen Liu, Jinling Xue, Yanli Wang, et al.
International Journal of Biological Sciences|October 2, 2023
Inhibition of Galectin-9 sensitizes tumors to anthracycline treatment via inducing antitumor immunityXian Sun, Wei-Jan Wang, Jilu Lang, et al.
Frontiers in Pharmacology|September 2, 2022
Effectiveness and safety analysis of SanHanHuaShi granules for the treatment of coronavirus disease 2019: Study protocol and statistical analysis plan for a randomized, parallel-controlled, open-label clinical trialYangyang Liu, Xi Chen, Hongan Wang, et al.
Journal for Immunotherapy of Cancer|July 15, 2025
Anti-galectin-9 therapy synergizes with EGFR inhibition to reprogram the tumor microenvironment and overcome immune evasionDongli Linghu, Jiaming Song, Liyan Gu, et al.
Nature Communications|February 6, 2021
Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapyRiyao Yang, Linlin Sun, Ching-Fei Li, et al.
Neuron|September 13, 2025
Corticotropin-releasing hormone signaling from piriform cortex to amygdala mediates social homophily in opioid addictionYu Huo, Xingyuan Wang, Xiaorui Lin, et al.
Cancer Research|March 12, 2020
Targeting Glycosylated PD-1 Induces Potent Antitumor ImmunityLinlin Sun, Chia-Wei Li, Ezra M Chung, et al.
The Journal of Clinical Investigation|July 16, 2019
IL-6/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasionLi-Chuan Chan, Chia-Wei Li, Weiya Xia, et al.
Pageof 32